The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
ADAPT: Adjuvant dynamic marker-adjusted personalized therapy trial optimizing risk assessment and therapy response prediction in early breast cancer.
Nadia Harbeck
No relevant relationships to disclose
Daniel Hofmann
No relevant relationships to disclose
Oleg Gluz
No relevant relationships to disclose
Ronald E. Kates
No relevant relationships to disclose
Sherko Kümmel
No relevant relationships to disclose
Benno Nuding
No relevant relationships to disclose
Mahdi Rezai
No relevant relationships to disclose
Manfred Kusche
No relevant relationships to disclose
Claudia Schumacher
No relevant relationships to disclose
Ulrike Nitz
No relevant relationships to disclose